Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: clinicopathological features and long-term outcomes following a pancreatectomy

  1. Antoñanzas, Javier 1
  2. A. Cienfuegos, Javier 123
  3. Hurtado-Pardo, Luis 1
  4. Panadero, Pablo 1
  5. Benito, Alberto 1
  6. Pardo, Fernando 1
  7. Rotellar, Fernando 1
  8. Martí-Cruchaga, Pablo 1
  9. Zozaya, Gabriel 1
  10. Valentí, Víctor 1
  11. Hernández Lizoain, José Luis 1
  1. 1 Clínica Universitaria de Navarra
    info

    Clínica Universitaria de Navarra

    Pamplona, España

    ROR https://ror.org/03phm3r45

  2. 2 Instituto de Investigación Sanitaria de Navarra
    info

    Instituto de Investigación Sanitaria de Navarra

    Pamplona, España

  3. 3 Instituto de Salud Carlos III
    info

    Instituto de Salud Carlos III

    Madrid, España

    ROR https://ror.org/00ca2c886

Erakutsi afiliazioak +
Aldizkaria:
Revista Española de Enfermedades Digestivas

ISSN: 1130-0108

Argitalpen urtea: 2018

Alea: 110

Zenbakia: 12

Orrialdeak: 768-774

Mota: Artikulua

DOI: 10.17235/REED.2018.5646/2018 GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Revista Española de Enfermedades Digestivas

Garapen Iraunkorreko Helburuak

Laburpena

Objective: the objective of this study was to analyze the anatomical and clinical features and long-term oncologic outcomes of 25 patients that underwent surgery due to intraductal papillary mucinous neoplasm of the pancreas. Material and methods: patients undergoing surgery for intraductal papillary mucinous neoplasm of the pancreas were identified from a prospective database of pancreatic resections. Demographic data, symptoms, type of surgery and type of lesion (branch type, main duct or mixed) were recorded. The lesions were classified into invasive (high grade dysplasia and carcinoma) and noninvasive (low- or intermediate-grade dysplasia). Postoperative complications were analyzed as well as the pattern of recurrence and disease-free survival at five and ten years. Results: the most common symptoms in the 25 patients (14 males and eleven females) were abdominal pain and weight loss. Eight (32%) cases were diagnosed incidentally. Twelve (48%) of the lesions were of the branch type, three affected the main duct and ten (40%) were mixed. Twelve cephalic duodenopancreatectomies and seven total pancreatectomies were performed; three were central; two, distal; and one, enucleation. Seven cases (32%) had an invasive phenotype. Three patients had locoregional and distant recurrence at six, 16 and 46 months after surgery with a median follow-up of 7.7 years. Disease-free survival at five and ten years for the noninvasive type was 94% and 57% for invasive phenotypes (p < 0.05). Conclusions: intraductal papillary mucinous neoplasm is a heterogeneous entity with well differentiated phenotypes, which requires a tailored strategy and treatment, as established in the current consensus guidelines due to its malignant potential.

Erreferentzia bibliografikoak

  • 10.1038/ajg.2018.14
  • 10.1001/jama.2016.4690
  • 3. Basturk O, Hong S-M, Wood LD et al. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am. J. Surg. Pathol. 2015; 39: 1730�41.
  • 4. Moris M, Wallace MB. Intraductal papillary mucinous neoplasms and mucinous cystadenomas: current status and recommendations. Rev. Esp. Enferm. Dig. 2017; 109: 358�367.
  • 10.1159/000090023
  • 6. Tanaka M, Fernandez-del Castillo C, Adsay V et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatol. Off. J. Int. Assoc. Pancreatol. ...[et al.] 2012; 12: 183�197.
  • 7. Ohashi K, Murakami Y, Takekoshi T. Four cases of �mucin-producing� cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982; 20: 348�351.
  • 8. European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789�804.
  • 9. Adsay V, Mino-Kenudson M, Furukawa T et al. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann. Surg. 2016; 263: 162�77.
  • 10.1053/j.gastro.2015.01.014
  • 11. Lennon AM, Manos LL, Hruban RH et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann. Surg. Oncol. 2014; 21: 3668�3674.
  • 12. Kneuertz PJ, Pitt HA, Bilimoria KY et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J. Gastrointest. Surg. 2012; 16: 1727�35.
  • 13. El Gammal AT, Izbicki JR. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management. Surg. Clin. North Am. 2018; 98: 141�155.
  • 14. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int. J. Surg. 2014; 12: 1495�1499.
  • 15. Adsay N V, Fukushima N, Furukawa T et al. Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al., eds. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer, 2010, pp.304�313.
  • 10.1016/j.surg.2015.03.021
  • 17. Pittman ME, Rao R, Hruban RH. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas. Arch. Pathol. Lab. Med. 2017; 141: 1606�1614.
  • 18. New classification of physical status. Anesthesiology 1963; 24: 111.
  • 10.1148/radiol.2482071578
  • 10.1136/gutjnl-2016-311615
  • 10.1097/SLA.0b013e3181724e4a
  • 22. Rotellar F, Pardo F, Cervera M et al. Laparoscopic distal pancreatectomy with or without splenectomy. Surgical technique. Surg.Endosc. 2006; 20 Suppl 1: S245.
  • 23. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240: 205�13.
  • 10.1016/j.surg.2005.05.001
  • 10.1016/j.surg.2007.02.001
  • 10.1016/j.surg.2007.05.005
  • 27. Cienfuegos JA, Benito A, Rotellar F. Agenesis of the dorsal pancreas associated with mucinous cysts and chronic calcific non-alcoholic pancreatitis. Rev. Esp. Enferm. Dig. 2017; 109: 395�396.
  • 10.1016/S0210-5705(16)30180-7
  • 29. Basturk O, Adsay V, Askan G et al. Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases. Am. J. Surg. Pathol. 2017; 41: 313�325.
  • 10.1146/annurev-pathol-011110-130235
  • 10.1097/MPA.0b013e31820a5975
  • 32. Hruban RH, Takaori K, Klimstra DS et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 2004; 28: 977�87.
  • 33. Tanaka M, Kobayashi K, Mizumoto K et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J. Gastroenterol. 2005; 40: 669�75.
  • 10.1097/00000658-200109000-00005
  • 10.1002/cncr.10203
  • 10.1016/j.surg.2012.05.033
  • 10.1001/archsurg.143.7.639
  • 38. Rodriguez JR, Salvia R, Crippa S et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007; 133: 72-9-10.
  • 10.1001/jamasurg.2016.5054
  • 10.1001/jamasurg.2016.3349
  • 41. Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J. Gastrointest. Surg. 2006; 10: 1199�210.
  • 42. Correa-Gallego C, Ferrone CR, Thayer SP et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010; 10: 144�50.
  • 10.1016/j.surg.2015.11.003
  • 10.2214/AJR.07.3340
  • 10.1016/j.pan.2014.07.006
  • 10.1097/01.sla.0000128306.90650.aa
  • 10.1097/MPA.0b013e3181b91cd0
  • 48. Tamura K, Ohtsuka T, Ideno N et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann. Surg. 2014; 259: 360�8.